ATE412750T1 - Antigen aus streptococcus pyogenes - Google Patents

Antigen aus streptococcus pyogenes

Info

Publication number
ATE412750T1
ATE412750T1 AT01951286T AT01951286T ATE412750T1 AT E412750 T1 ATE412750 T1 AT E412750T1 AT 01951286 T AT01951286 T AT 01951286T AT 01951286 T AT01951286 T AT 01951286T AT E412750 T1 ATE412750 T1 AT E412750T1
Authority
AT
Austria
Prior art keywords
antigen
streptococcus pyogenes
streptococcus
prophylaxis
antigens
Prior art date
Application number
AT01951286T
Other languages
English (en)
Inventor
Denis Martin
Josee Hamel
Bernard Brodeur
Stephane Rioux
Martine Boyer
Original Assignee
Id Biomedical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Id Biomedical Corp filed Critical Id Biomedical Corp
Application granted granted Critical
Publication of ATE412750T1 publication Critical patent/ATE412750T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01951286T 2000-07-06 2001-07-06 Antigen aus streptococcus pyogenes ATE412750T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21646500P 2000-07-06 2000-07-06

Publications (1)

Publication Number Publication Date
ATE412750T1 true ATE412750T1 (de) 2008-11-15

Family

ID=22807177

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01951286T ATE412750T1 (de) 2000-07-06 2001-07-06 Antigen aus streptococcus pyogenes

Country Status (10)

Country Link
US (2) US7247308B2 (de)
EP (1) EP1297145B1 (de)
JP (1) JP4718099B2 (de)
AT (1) ATE412750T1 (de)
AU (1) AU7227001A (de)
BR (1) BR0112497A (de)
CA (1) CA2413576C (de)
DE (1) DE60136360D1 (de)
ES (1) ES2316458T3 (de)
WO (1) WO2002004495A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7227001A (en) 2000-07-06 2002-01-21 Shire Biochem Inc Streptococcus pyogenes antigens
AU1412702A (en) * 2000-10-27 2002-05-06 Chiron Spa Nucleic acids and proteins from streptococcus groups a and b
AU1686302A (en) * 2000-12-21 2002-07-01 Shire Biochem Inc Streptococcus pyogenes antigens and corresponding dna fragments
AU2003260102A1 (en) * 2002-08-26 2004-03-11 Chiron Corporation Conserved and specific streptococcal genomes
PT1648500E (pt) 2003-07-31 2014-10-10 Novartis Vaccines & Diagnostic Composições imunogénicas para estreptococos piogenes
WO2005017093A2 (en) * 2003-08-15 2005-02-24 Id Biomedical Corporation Polypeptides of streptococcus pyogenes
US8945589B2 (en) * 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
EP1784211A4 (de) 2004-07-29 2010-06-30 Novartis Vaccines & Diagnostic Immunogene zusammensetzungen für grampositive bakterien wie streptococcus agalactiae
JP2008544949A (ja) * 2004-10-08 2008-12-11 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 化膿性レンサ球菌のための免疫激性組成物および治療用組成物
GB2428006A (en) * 2005-07-07 2007-01-17 Jevgenis Morov AMI-3 vaccine comprising group A Streptococcus pyogenes bacteria
ATE522541T1 (de) * 2006-06-09 2011-09-15 Novartis Ag Bakterielle adhäsine konformere
AU2007348285A1 (en) * 2006-10-30 2008-09-12 Novartis Ag Immunogenic and therapeutic compositions for streptococcus pyogenes
MX2010002773A (es) 2007-09-12 2010-03-31 Novartis Ag Antigenos mutantes de gas57 y anticuerpos de gas57.
CA2709927C (en) 2007-12-21 2017-05-16 Novartis Ag Mutant forms of streptolysin o
US8697085B2 (en) 2011-06-17 2014-04-15 University Of Tennessee Research Foundation Group A Streptococcus multivalent vaccine
WO2014124446A1 (en) 2013-02-11 2014-08-14 University Of Tennessee Research Foundation Group a streptococcal m-related proteins and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0916726A1 (de) * 1997-11-13 1999-05-19 Rijksuniversiteit te Groningen Befestigungs-Substanzen an Mikroorganismen
AU7227001A (en) * 2000-07-06 2002-01-21 Shire Biochem Inc Streptococcus pyogenes antigens

Also Published As

Publication number Publication date
WO2002004495A3 (en) 2002-06-13
US7247308B2 (en) 2007-07-24
DE60136360D1 (de) 2008-12-11
BR0112497A (pt) 2003-11-25
EP1297145B1 (de) 2008-10-29
US20030165528A1 (en) 2003-09-04
US20080038268A1 (en) 2008-02-14
US7811585B2 (en) 2010-10-12
AU7227001A (en) 2002-01-21
JP4718099B2 (ja) 2011-07-06
WO2002004495A2 (en) 2002-01-17
ES2316458T3 (es) 2009-04-16
EP1297145A2 (de) 2003-04-02
JP2004502446A (ja) 2004-01-29
CA2413576A1 (en) 2002-01-17
CA2413576C (en) 2012-11-13

Similar Documents

Publication Publication Date Title
BE2021C506I2 (de)
DE60136360D1 (de) Antigen aus streptococcus pyogenes
ATE542829T1 (de) Impfstoff
ATE426412T1 (de) Adjuvante influenza-vakzine
WO2004030608A3 (en) Nanoemulsion vaccines
AU2001278003A1 (en) Bacteriophage having multiple host range
NO20024246D0 (no) Endret stamme av det modifiserte vacciniaviruset (Ankara MVA)
ATE320493T1 (de) Modifizierung des hepatitis b kernantigens
DK1255826T3 (da) Automatisering af proteindesign for proteinbiblioteker
ATE227134T1 (de) Chitosan-impfstoff-zusammensetzungen zur intranasalen verabreichung und anwendungen
MY125202A (en) Vaccine
WO2002036790A3 (en) Influenza virus vector for infection of dendritic cells
ATE426026T1 (de) Chimare arterivirus-ahnliche partikel
WO2006042027A8 (en) Immunogenic and therapeutic compositions for streptococcus pyogenes
AP2002002685A0 (en) Use of flavivirus for the expression of protein epitpoes and development of new live attenuated vaccine virus to immune against flavivirus and other infectious agents
BRPI0113155C1 (pt) métodos para produção de uma vacina para hepatite b e de um antígeno de superfície para hepatite b
ATE392216T1 (de) Mycobakterieller impfstoff
DK1395283T3 (da) Heterolog beskyttelse induceret ved immunisering med Invaplex-vaccine
DE60213802D1 (de) Cak inhibitoren und deren verwendungen
IL156799A0 (en) Peptides having affinity for the gp120 viral protein and use thereof
DE60235223D1 (de) Streptococcus pyogenes polypeptide und entsprechende dna fragmente
EP1543838A4 (de) Vakzine gegen infektiöse katzen-peritonitis
SG147465A1 (en) Vaccine
DK0792347T3 (da) Fremgangsmåder til fremstilling af forbedrede antigene Heliobacter sp. og vacciner omfattende samme
WO2003059252A3 (en) Use of a novel cell surface protease from group b streptococcus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties